Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.
New York, New York, United States In 2008 was created Athyrium Capital Management, LP, which is appeared as VC. The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.
The fund is constantly included in 2-6 deals per year. The top amount of exits for fund were in 2014. Comparing to the other companies, this Athyrium Capital Management, LP performs on 10 percentage points more the average number of lead investments. The real fund results show that this VC is 36 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of more than 100 millions dollars.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Health Diagnostics, E-Commerce. Among the various public portfolio startups of the fund, we may underline Clover Health, VillageMD, TRIA Beauty Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Athyrium Capital Management, LP, startups are often financed by Oxford Finance LLC, Avista Capital Partners, WFD Ventures. The meaningful sponsors for the fund in investment in the same round are First Round Capital, Wildcat Venture Partners, Vivo Capital. In the next rounds fund is usually obtained by Greenoaks Capital, Wildcat Venture Partners, Sequoia Capital.
This organization was formed by Jeffrey A Ferrell. The overall number of key employees were 8.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 7cool | China, Jiangsu, Wuxi Shi |
| Beijing Changping Technology Innodevelop Group | Beijing, Beijing, China |
| Developing World Markets | Connecticut, Stamford, United States |
| Henglu Assets | China, Shanghai |
| NXT | - |
| Research Corporation Technologies | Arizona, Tucson, United States |
| Shonai Bank | Japan, Tsuruoka, Yamagata Prefecture |
| Sirius Angel Fund | Central, Central Region, Singapore |
| Y Experiment | Greater Poland Voivodeship, Poland, Poznań |
| Yorkville Advisors | Mountainside, New Jersey, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Basilea Pharmaceutica | $81M | 07 Sep 2022 | Basel, Basel-Stadt, Switzerland | ||
uMotif | $27M | 25 May 2022 | London, England, United Kingdom | ||
Revance Therapeutics | $300M | 21 Mar 2022 | California, United States | ||
Puma Biotechnology | $10M | 10 Mar 2022 | Los Angeles, California, United States | ||
Osmotica Pharmaceutical | $100M | 07 Oct 2021 | Marietta, Georgia, United States | ||
Puma Biotechnology | $125M | 26 Jul 2021 | Los Angeles, California, United States | ||
BioCryst Pharmaceuticals | $325M | 07 Dec 2020 | Birmingham, Alabama, United States | ||
ArisGlobal | 01 Jul 2019 | Coral Gables, Florida, United States | |||
Secura Bio | $90M | 05 Mar 2019 | Las Vegas, Nevada, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 
Get matched with relevant funds
